Denmark-based LEO Pharma’s research and development (R&D) unit LEO Science and Tech Hub has partnered with US-based Wellman Centre for Photomedicine at Massachusetts General Hospital to develop new imaging technology and a disposable microbiopsy device.

Under the collaboration, LEO Science will provide research funding to support two separate development programmes.

With expertise on microscopy and spectroscopy, the lab led by Harvard Medical School assistant professor Conor Evans will work towards developing imaging technologies for non-invasive, high-resolution, and real-time pharmacokinetic/pharmacodynamic (PK/PD) measurements.

The lab will make use of its coherent Raman scattering (CRS) technology that allows chemically specific imaging by identifying molecular vibrations specific to drugs and tissues.

"The firm’s partnership with the R Rox Anderson’s Lab will involve the development of a painless, suture-free, disposable microbiopsy device to potentially enable a non-scarring sampling procedure of full-thickness skin microbiopsies."

LEO Science and Tech Hub vice-president Dr Michael Sierra said: "At LEO Science and Tech Hub, we firmly believe in the power of collective effort and are always seeking cutting-edge technologies to advance non-invasive biopsy and imaging technologies for patients with skin diseases.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Tick here to opt out of curated industry news, reports, and event updates from Medical Device Network.

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The device will also be used to carry out frequent sampling in clinical studies to aid further understanding of disease profile.

In June, the Hub has also formed an alliance with The Karp Lab at Brigham and Women’s Hospital for minimally invasive technologies to assess dermal biomarkers, and with Novopyxis for a needle-free aerosol-based drug delivery device to deliver skin treatments topically.

Image: Coherent Raman imaging used to picture mouse skin ‘tuned’ into the vibrational frequencies of lipids at the surface of the skin. Photo: courtesy of LEO Science and Tech Hub.